Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo
NCT06548360Phase 3Recruiting
- Sponsor
- Incyte
- Start
- Jan 2025
- Primary completion
- Jun 2028
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of ruxolitinib cream in nonsegmental vitiligo (NSV), sponsored by Incyte. Started Jan 2025; status: recruiting.
02
Drugs
ruxolitinib cream
03
Conditions
nonsegmental vitiligo (NSV)
Beyond the preview
Go deeper on NCT06548360.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06548360.